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Abstract 
 
 Four groups of experimental mice are studied in this experiment following 
intentional exposure to murine norovirus (MNV). Two groups are exposed to the 
virus at different points in their lives, and the other two are not infected and 
studied alongside the other groups as controls.  
Past research has indicated that B and T immune cells are not essential to 
MNV resistance2. Additionally, antibody production against MNV has shown to be 
slow as infection progresses1. Thus, the expected results from the experiment 
are that the mice with longer infections of MNV will have larger quantities of IgG 
than those more recently infected with the virus. Immunological data gathered 
from these groups is compared to IgG counts from control mice, which are 
comprised of pathologically clean mice of the same strain as the sentinel mice 
infected with MNV and the same strain as the colony with innate exposure to 
MNV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
 Murine norovirus (MNV) is the most common pathogenic species found in 
laboratory mice. An RNA, non-enveloped virus, MNV is of the family Caliciviridae 
and is transmitted from host to host via the fecal-oral route. Though the virus is 
typically asymptomatic in mice with competent immune systems, it has caused 
more detrimental pathology in mice with immunodeficiencies, particularly mice 
with damaged or lost STAT1 genes, which encode proteins that respond to 
interferon stimulation, particularly interferon-gamma (IFN-γ), a critical component 
to development of innate and adaptive immunity6. Mice with deficiencies in 
STAT1 genes that are infected with the virus have symptoms including wasting 
and death. This lead to the assumption that STAT1 genes are crucial in MNV 
defense in mice1,2. Less severe infections have shown inflammation in the liver, 
lungs and peritoneal cavities3. 
 Interest in the virus has been limited due to its noninvasive nature with 
research, and thus little literature is found on MNV. However, investigators with 
an interest in studying immunology using murine models may have their results 
questioned if their mice are infected with MNV. Those studying mice with 
knocked-out or knocked-down STAT1 genes may also have difficulty in their 
experiment if the colonies used are infected with the virus. It is for these reasons 
and the fact that the virus is so prevalent that the experiment chose to focus on 
mice colonies infected with MNV. 
 The experiment detailed in this report is a case study of two different 
groups of mice housed in The University of Akron Research Vivarium (UARV). 
The key focus was the relationship between length of infection of MNV and the 
immunological results, showcased in this experiment as Immunoglobulin G (IgG) 
counts of infected mice. IgG counts were chosen as the dependent variable 
because of the nature of antibody count, or IgG count, increasing during viral 
infection.  
One group of mice, which represent a colony with historically positive 
serology test results for MNV, are assumed to have been exposed to the virus 
since birth, yet innate immunities have prevented any symptoms from evolving. 
The other group are sentinel mice that are exposed to the virus after being 
introduced into the colony from an external, MNV-negative source, and thus are 
infected well after birth. Two other groups act as controls, in that neither are 
exposed to MNV and have never received positive serology test results for MNV. 
 Past research has indicated that B and T immune cells are not essential to 
MNV resistance2. Additionally, antibody production against MNV has shown to be 
slow as infection progresses1. Thus, the expected results from the experiment 
are that the mice with longer infections of MNV will have larger quantities of IgG 
than those more recently infected with the virus. Immunological data gathered 
from these groups is compared to IgG counts from control mice, which are 
comprised of pathologically clean mice of the same strain as the sentinel mice 
infected with MNV and the same strain as the colony with innate exposure to 
MNV. 
 
Methods 
 
 The experiment focused on 4 experimental groups. Group 1 (n=3) was 
composed of sentinel mice intentionally exposed to soiled bedding and feces 
from Group 2. Group 2 (n=2) included mice representing the colony with 
historically positive serology tests for MNV. Group 3 (n=3) included sentinel mice 
not exposed to MNV, yet exposed to feces from Group 4. Group 4 (n=2) included 
control mice with historically MNV-negative serology test results.  
Group 2 (1 female and 1 male, strain C57BL6) mice were bred in-house. 
Group 4 (female, strain C57BL6) were imported from The Jackson Laboratory in 
Sacramento, California. Sentinel mice, which were used in experimental Groups 
1 and 3 are female, strain CF-1 and originate from Charles River Laboratories in 
Raleigh, North Carolina.  
The experiment performed was completed in tandem with the sentinel 
testing program at the UARV, which was approved by the Institutional Animal 
Care and Use Committee (IACUC) at The University of Akron under protocol 13-
3C. 
Mice in Group 1 were housed with a colony of mice with a history of MNV 
infection, showcased by positive results following serology tests. During weekly 
cage changes, dirty bedding containing fecal material from each cage in the 
colony was placed in Group 1’s cage, allowing for transmission of any pathogens 
present in the colony. This procedure was performed for Group 3, with the 
exception that these mice were housed with a colony with historically clean 
serology test results. Groups 2 and 4 were donated from the colony with MNV 
and the clean colony, respectively.  
Sentinel mice were housed with the colonies of experimental mice for a 
period of eight weeks, allowing enough time for transmission of any present 
pathogens. At the end of the eight weeks, the sentinel mice and the groups 
representing the colonies the sentinels were housed with were euthanized and 
serology samples were collected. 
Prior to euthanasia, mice in each group were anesthetized 
intraperitoneally with a combination of ketamine (75-125 mL/kg) and 
acepromazine maleate (2.5-4 mL/kg) in a volume of approximately 0.1-0.25 mL 
per 100 g of body weight. The ketamine and acepromazine maleate were 
distributed from Vedco, Inc. and Boehringer Ingelheim Vetmedica, Inc., 
respectively, from St. Joseph, Missouri.  
Blood draws, anesthesia, and euthanasia were completed for each group 
using a 1-mL syringe and 25-gauge, 5/8-inch long needles vended from Becton-
Dickinson. Blood was collected via cardiac puncture and placed into a Becton-
Dickinson vacutainer serum tube, each group having its own tube. The serum 
tube contained an clot-activator additive and was coated with silicon on the 
interior. Blood from each mice belonging to the group was placed in the tube to 
properly represent all in the experimental group. All mice were euthanized via an 
overdose of pentobarbital-containing euthanasia solution Beuthanasia-D Special 
(390 mg/mL), distributed by Schering-Plough Animal Health in Union, New 
Jersey. Euthanasia was given at a minimum dose of 100-125 mg/kg. Death was 
confirmed by lack of respiration and heartbeat. Following death, a gross 
necropsy was performed on each mouse to observe for any anomalies. Anal 
tapes, fecal floats, and cage swabs were performed to test for any presence of 
ecto- and/or endoparasites. Anal tapes and fecal floats were performed in-house. 
Cage swabs were sent to IDEXX BioResearch and analyzed via PCR. 
The blood in each vacutainer tube was separated into serum and plasma 
components via a Speedfuge Centrifuge HSC10K made by Savant Instruments, 
Inc. from Farmingdale, New York. Serum from each tube was collected using a 
microliter pipette and placed inside four individual Eppendorf microcentrifuge 
tubes for each group. The serum samples were sent to IDEXX BioResearch in 
Columbia, Missouri, where serology tests were performed to test for antibodies 
against common pathogens in laboratory mice colonies. In addition to the Basic 
Serology examination, IDEXX BioResearch also provided immunoglobulin counts 
(µg/mL) for each serum sample.  
 
Results 
  
 Detection of MNV by IDEXX BioResearch was completed via Multiplex 
Fluorescent Immunoassay (MFI). A MNV antigen created by IDEXX was tagged 
with fluorescent beads to identify presence of IgG antibodies against the virus. 
Intensity of fluorescence was calculated for each treatment group in the 
experiment if MNV was present in the serum. 
 According to the Basic Serology results from IDEXX, Group 1 tested 
positive for MNV infection and Groups 2-4 tested negative (Table 1). Group 1 
showed MFI (median fluorescent intensity) values of 14,500 – 15,499 for MNV, 
high above the baseline for detection (MFI > 2.000). No MFI values were 
reported for any other group. 
 Group 2 showed the highest number of IgG in the serum collected from 
the members (1,907 µg/mL). Group 1 had the second highest number at 1,114 
µg/mL). Groups 3 and 4 had the lowest immunoglobulin counts, at 757 µg/mL 
and 812 µg/mL respectively. Results from the t-test showed that the differences 
in values are statistically significant (p-value = 0.011). A graph exhibiting the IgG 
counts can be found in Figure 1. 
 No significant findings of abnormal physiological detail, clinical health 
concerns, or ectoparasites were found upon gross necropsy. Anal tapes, fecal 
floats and cage swabs showed no evidence of parasitic infection. Basic Serology 
results from IDEXX displayed no pathogenic species, other than MNV, had 
infected the mice from Groups 1-4. 
 
 
 
 
 
 
 
 
MNV Baseline Group 1 Group 2 Group 3 Group 4 
MNV Purified 
Virus 
MFI > 
2.000 
+15 -- -- -- 
MNV VP1 
Recombinant 
MFI > 
3.750 
+18 -- -- -- 
Table 1. Detection of MNV was completed by MFI. Fluorescence was detected in Group 1 
mice with a value between 14,500 – 15,499 MFI. Recombinant viruses were detected as well 
at a value between 17,500 – 18,499 MFI. MNV was not detected in any other treatment 
group in the experiment. Table adapted from IDEXX BioResearch Case 2423-2016. 
	
Figure 1.  Graph shows immunoglobulin counts between Groups 1-4. Serum used per 
group was a collection of blood donated by each member of the group, so counts are 
aggregates. Group 2 had the highest number of IgG, followed by Group 1, 4 and 3. T-test 
showed relationship between treatment group and IgG count is statistically significant (p-
value = 0.011449). Raw data supplied by IDEXX BioResearch. 
Discussion 
 
 The purpose of the experiment was to observe the effects of progression 
of MNV infection on the immunology of mice. Groups 1 and 2 were the key focus, 
as they differed in length of exposure to the virus, with Group 2 having the virus 
since birth and Group 1 being exposed to it around 6 weeks of age. Groups 3 
and 4 acted as controls, as neither group was exposed to MNV or had any 
history of pathogenic infection. The expected result of the case study was that 
mice immediately exposed to the virus after birth (Group 2) were going to have 
higher IgG counts than mice exposed to it after being introduced into the colony 
(Group 1). 
 The results from the experiment showed that the hypothesis held true: 
Group 2 had a higher immunoglobulin count (1,907 µg/mL) than Group 1 (1,114 
µg/mL). Exact measurements are shown in the results and a bar graph exhibiting 
the relationships between IgG counts between groups are shown in Figure 1. 
However, serology test results showed that Group 2 tested negative for MNV 
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infection (Table 1), a possibility not initially considered prior to experimentation. 
The colony that Group 2 was donated from had previously tested positive for 
MNV, yet this fact shows that even though the virus is present in the colony, it 
does not necessarily mean all mice are infected. This explains the results from 
the serology test. 
 However, this calls into question the results seen in the IgG counts. Group 
1’s serum contained antibodies against MNV, which would explain the higher IgG 
counts when compared to mice of the same strain in Group 3, which were not 
exposed to the virus. Group 2 had higher IgG counts than mice of the same 
strain not infected with MNV in Group 4. Group 2 had higher numbers of 
antibodies in their serum than Group 1, the only group infected with MNV.  
 Experimental error could have caused the results seen in the experiment. 
For example, MNV antibodies could have been present in Group 2’s serum 
sample but at too low of concentrations to be detected by MFI. Excluding the 
possibility of experimental error, higher IgG counts in Group 2 mice could have 
been diet-induced. 
 C57BL6 mice are highly susceptible to diet-induced obesity, a trait known 
to cause higher levels of serum IgG4. In an experiment conducted by Mohammed 
N. et al. in 2012, strain C57BL6 mice fed a high-fat diet, when compared to mice 
with normal and low-fat diets, had more antibodies present in their serum. The 
IgG targeted specific pathogenic strains of common gut bacteria, including 
Escherichia coli5. 
 The mice in Group 2 were fed high-fat diets prior to being donated to 
encourage breeding behavior. The diet caused the dam and sire to become 
obese, which, given the results of Mohammed N. et al.’s experiment, may have 
explained why their IgG counts were elevated, even more so than mice infected 
with MNV. Group 4, the same strain as Group 2, was fed a diet containing normal 
quantities of fat and results in Figure 1 show that, relatively speaking, its IgG 
numbers were low. Thus, it is possible that prolonged consumption of high-fat 
food and subsequent obesity causes more of an immune response than MNV 
infection. 
The fact that healthy B and T cells do not have as much as an effect on 
fighting MNV infection as STAT1 genes might also explain why Group 1 did not 
produce as much IgG. Additionally, if Group 2’s obesity caused an increase in 
harmful species of gut bacteria, multiple IgG’s targeted against multiple antigens 
created by these bacteria could easily explain heightened IgG levels in blood 
serum. Group 1, while having MNV, was not fed a high-fat diet and therefore 
could have not been hosts for associated pathogenic bacterial species, thus no 
antibodies were produced. 
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